Literature DB >> 35673444

Familial hypercholesterolemia in an Iranian family due to a mutation in the APOE gene (first case report).

Shahab Noorian1, Rezvan Razmandeh2, Roshanak Jazayeri3,4.   

Abstract

Familial Hypercholesterolemia is an autosomal, dominant genetic disorder associated with premature cardiovascular disease (CVD). Mutations in the LDLR, APOB, and PCSK9 genes cause the FH phenotype, but in 20% of FH patients, mutations in other genes cause FH. In this regard, we investigated the genetic basis of an Autosomal Dominant Hypercholesterolemia (ADH) phenotype in an Iranian family via next-generation exome sequencing with a panel of hyperlipidemia. We report the first case of FH in an Iranian family due to a mutation in the APOE gene. A 10-year-old female was referred to our genetic clinic with a family history of hypercholesterolemia and high cholesterol level at the age of 3. Evaluation of the lipid profile showed the off total cholesterol of 338 mg/dl, low-density lipoprotein cholesterol (LDL-C of 247 mg/dl(. We identified a mutation in the APOE gene, c.500_502del /p. Leu167del confirmed co-segregation in three individuals of the family from three generations. This in-frame mutation identified here, the first report in Iran, confirms previous reports that ADH can be caused by mutations within the APOE gene and strongly introduces it as the 4th gene that must be checked in the genetic investigating of FH. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  APOE gene; Cardio vascular disease; Familial hypercholesterolemia; Mutation; Next generation sequencing; Screening

Year:  2022        PMID: 35673444      PMCID: PMC9167334          DOI: 10.1007/s40200-022-01007-1

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  19 in total

1.  Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].

Authors:  T T Nguyen; K E Kruckeberg; J F O'Brien; Z S Ji; P S Karnes; T B Crotty; I D Hay; R W Mahley; T O'Brien
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  An unusual case of severe hypertriglyceridemia and splenomegaly.

Authors:  Amit R Rahalkar; Jian Wang; Sandra Sirrs; James Dimmick; Daniel Holmes; Nadine Urquhart; Robert A Hegele; Andre Mattman
Journal:  Clin Chem       Date:  2008-03       Impact factor: 8.327

3.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.

Authors:  Dalya Marks; David Wonderling; Margaret Thorogood; Helen Lambert; Steve E Humphries; H Andrew W Neil
Journal:  BMJ       Date:  2002-06-01

4.  Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.

Authors:  Emily S van Aalst-Cohen; Angelique C M Jansen; Michael W T Tanck; Joep C Defesche; Mieke D Trip; Peter J Lansberg; Anton F H Stalenhoef; John J P Kastelein
Journal:  Eur Heart J       Date:  2006-07-06       Impact factor: 29.983

5.  The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes.

Authors:  Ana Cenarro; Aitor Etxebarria; Isabel de Castro-Orós; Marianne Stef; Ana M Bea; Lourdes Palacios; Rocío Mateo-Gallego; Asier Benito-Vicente; Helena Ostolaza; Teresa Tejedor; César Martín; Fernando Civeira
Journal:  J Clin Endocrinol Metab       Date:  2016-03-25       Impact factor: 5.958

6.  Homozygous familial hypercholesterolemia among French Canadians in Québec Province.

Authors:  S Moorjani; M Roy; C Gagné; J Davignon; D Brun; M Toussaint; M Lambert; L Campeau; S Blaichman; P Lupien
Journal:  Arteriosclerosis       Date:  1989 Mar-Apr

7.  APOE p.Leu167del mutation in familial hypercholesterolemia.

Authors:  Zuhier Awan; Hong Y Choi; Nathan Stitziel; Isabelle Ruel; Mary Aderayo Bamimore; Regina Husa; Marie-Helene Gagnon; Rui-Hao L Wang; Gina M Peloso; Robert A Hegele; Nabil G Seidah; Sekar Kathiresan; Jacques Genest
Journal:  Atherosclerosis       Date:  2013-09-19       Impact factor: 5.162

8.  Familial hypercholesterolaemia presenting with coronary artery disease in a young patient.

Authors:  K S Subramani; Vikram B Kolhari; C N Manjunath; Shivkumar Bhairappa
Journal:  BMJ Case Rep       Date:  2013-03-20

Review 9.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Authors:  Albert Wiegman; Samuel S Gidding; Gerald F Watts; M John Chapman; Henry N Ginsberg; Marina Cuchel; Leiv Ose; Maurizio Averna; Catherine Boileau; Jan Borén; Eric Bruckert; Alberico L Catapano; Joep C Defesche; Olivier S Descamps; Robert A Hegele; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Jan Albert Kuivenhoven; Luis Masana; Børge G Nordestgaard; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Elisabeth Steinhagen-Thiessen; Erik S Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Olov Wiklund
Journal:  Eur Heart J       Date:  2015-05-25       Impact factor: 29.983

10.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.

Authors:  Jorie Versmissen; Daniëlla M Oosterveer; Mojgan Yazdanpanah; Joep C Defesche; Dick C G Basart; Anho H Liem; Jan Heeringa; Jacqueline C Witteman; Peter J Lansberg; John J P Kastelein; Eric J G Sijbrands
Journal:  BMJ       Date:  2008-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.